These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 18690834)

  • 1. Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies.
    Alonso AC; Li B; Grundke-Iqbal I; Iqbal K
    Curr Alzheimer Res; 2008 Aug; 5(4):375-84. PubMed ID: 18690834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau-induced neurodegeneration: mechanisms and targets.
    Beharry C; Cohen LS; Di J; Ibrahim K; Briffa-Mirabella S; Alonso Adel C
    Neurosci Bull; 2014 Apr; 30(2):346-58. PubMed ID: 24733656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-translational modifications of tau protein in Alzheimer's disease.
    Gong CX; Liu F; Grundke-Iqbal I; Iqbal K
    J Neural Transm (Vienna); 2005 Jun; 112(6):813-38. PubMed ID: 15517432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tau pathology in Alzheimer disease and other tauopathies.
    Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttranslational modifications of tau--role in human tauopathies and modeling in transgenic animals.
    Chen F; David D; Ferrari A; Götz J
    Curr Drug Targets; 2004 Aug; 5(6):503-15. PubMed ID: 15270197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-translational modifications of tau protein: implications for Alzheimer's disease.
    Martin L; Latypova X; Terro F
    Neurochem Int; 2011 Mar; 58(4):458-71. PubMed ID: 21215781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau hyperphosphorylation induces apoptotic escape and triggers neurodegeneration in Alzheimer's disease.
    Wang JZ; Wang ZH; Tian Q
    Neurosci Bull; 2014 Apr; 30(2):359-66. PubMed ID: 24627329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death.
    Feinstein SC; Wilson L
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):268-79. PubMed ID: 15615645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-translational modifications of tau protein.
    Pevalova M; Filipcik P; Novak M; Avila J; Iqbal K
    Bratisl Lek Listy; 2006; 107(9-10):346-53. PubMed ID: 17262986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau truncation is a productive posttranslational modification of neurofibrillary degeneration in Alzheimer's disease.
    Kovacech B; Novak M
    Curr Alzheimer Res; 2010 Dec; 7(8):708-16. PubMed ID: 20678071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau alteration and neuronal degeneration in tauopathies: mechanisms and models.
    Brandt R; Hundelt M; Shahani N
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):331-54. PubMed ID: 15615650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An acetylation-phosphorylation switch that regulates tau aggregation propensity and function.
    Carlomagno Y; Chung DC; Yue M; Castanedes-Casey M; Madden BJ; Dunmore J; Tong J; DeTure M; Dickson DW; Petrucelli L; Cook C
    J Biol Chem; 2017 Sep; 292(37):15277-15286. PubMed ID: 28760828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.
    Wang JZ; Xia YY; Grundke-Iqbal I; Iqbal K
    J Alzheimers Dis; 2013; 33 Suppl 1():S123-39. PubMed ID: 22710920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTDP-17 Mutations Alter the Aggregation and Microtubule Stabilization Propensity of Tau in an Isoform-Specific Fashion.
    Mutreja Y; Combs B; Gamblin TC
    Biochemistry; 2019 Feb; 58(6):742-754. PubMed ID: 30562452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tauopathies.
    Hernández F; Avila J
    Cell Mol Life Sci; 2007 Sep; 64(17):2219-33. PubMed ID: 17604998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau and Axonal Transport Misregulation in Tauopathies.
    Combs B; Mueller RL; Morfini G; Brady ST; Kanaan NM
    Adv Exp Med Biol; 2019; 1184():81-95. PubMed ID: 32096030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau Abnormalities and the Potential Therapy in Alzheimer's Disease.
    Almansoub HAMM; Tang H; Wu Y; Wang DQ; Mahaman YAR; Wei N; Almansob YAM; He W; Liu D
    J Alzheimers Dis; 2019; 67(1):13-33. PubMed ID: 30507581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of tau phosphorylation and cleavage in neuronal cell death.
    Chun W; Johnson GV
    Front Biosci; 2007 Jan; 12():733-56. PubMed ID: 17127334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic and network functions of the microtubule-associated protein tau: Implications for tau-based therapies.
    Bakota L; Ussif A; Jeserich G; Brandt R
    Mol Cell Neurosci; 2017 Oct; 84():132-141. PubMed ID: 28318914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau binds ATP and induces its aggregation.
    Farid M; Corbo CP; Alonso Adel C
    Microsc Res Tech; 2014 Feb; 77(2):133-7. PubMed ID: 24258797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.